title: Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery disease.
abstract: Acute myocardial infarction (AMI) is more frequent in winter months than in summer months. The aetiologic mechanisms underlying this seasonal pattern are poorly understood. We investigate whether seasonal variation of metabolic and haemostatic coronary risk factors exists, and whether this variation is more pronounced in subjects with coronary artery disease (CAD). In 82 subjects (47 free of clinical signs of CAD and in 35 survivors of AMI), measurements of body mass index (BMI), lipoproteins, glucose, insulin, plasminogen activator inhibitor-1, tissue-type plasminogen activator (t-PA), euglobulin clot lysis time, fibrinogen, and platelet count were performed twice in the cold months (December and March) and twice in the warm months (June and September). Significantly higher BMI (26.8 versus 26.2 kg/m2, P < 0.01), glucose (5.5 versus 5.1 mmol/l, P < 0.01), total cholesterol (5.61 versus 5.32 mmol/l, P < 0.05), low-density lipoprotein cholesterol (3.63 versus 3.34 mmol/l, P < 0.05), triglycerides (1.79 versus 1.61 mmol/l, P < 0.01), Lp(a) (270.7 versus 237.5 mg/l, P < 0.01), fibrinogen level (3.50 versus 2.95 g/l, P < 0.00001), platelet count (212 x 10(9) versus 173 x 10(9)/l, P < 0.01) and significantly lower high-density lipoprotein cholesterol level (1.22 versus 1.28 mmol/l, P < 0.05) were observed in the cold months compared with the warm months. Significant seasonal variation of t-PA activity (1.19 versus 0.87 IU/ml, P = 0.015) and t-PA antigen (8.5 versus 7.3 ng/ml, P = 0.05) was demonstrated only in subjects with CAD. Clustering of peak values of several metabolic and haemostatic coronary risk factors was observed in winter months. This variation might be of aetiopathogenetic importance for the seasonal pattern of acute myocardial infarction.
authors.affiliation: Department of Angiology, University Medical Centre, Ljubljana, Slovenia. alenka.mavri@trnovo.kclj.si
authors.forename: A
authors.initials: A
authors.lastname: Mavri
authors.forename: B
authors.initials: B
authors.lastname: Guzic-Salobir
authors.forename: B
authors.initials: B
authors.lastname: Salobir-Pajnic
authors.forename: I
authors.initials: I
authors.lastname: Keber
authors.forename: J
authors.initials: J
authors.lastname: Stare
authors.forename: M
authors.initials: M
authors.lastname: Stegnar
mesh_terms: D000208:Acute Disease; D000328:Adult; D001779:Blood Coagulation Factors / Q000378:metabolism; D001786:Blood Glucose / Q000032:analysis; D015992:Body Mass Index; D016022:Case-Control Studies; D003324:Coronary Artery Disease / Q000097:blood / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D006490:Hemostatics / Q000097:blood*; D006801:Humans; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012621:Seasons
chemical_list: D001779:Blood Coagulation Factors; D001786:Blood Glucose; D006490:Hemostatics; D008055:Lipids